Evolent Health, Inc. (NYSE:EVH) Shares Sold by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC decreased its holdings in Evolent Health, Inc. (NYSE:EVH) by 20.2% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 734,486 shares of the technology company’s stock after selling 185,819 shares during the quarter. Silvercrest Asset Management Group LLC owned about 0.64% of Evolent Health worth $24,084,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in EVH. ICA Group Wealth Management LLC acquired a new stake in Evolent Health in the fourth quarter worth about $33,000. Headlands Technologies LLC acquired a new stake in Evolent Health in the 1st quarter worth approximately $46,000. Signaturefd LLC boosted its stake in Evolent Health by 1,470.7% in the 4th quarter. Signaturefd LLC now owns 1,445 shares of the technology company’s stock worth $48,000 after purchasing an additional 1,353 shares in the last quarter. NBC Securities Inc. purchased a new stake in Evolent Health during the 4th quarter worth approximately $69,000. Finally, Banque Cantonale Vaudoise acquired a new position in Evolent Health during the 1st quarter valued at approximately $88,000.

Evolent Health Price Performance

Shares of NYSE:EVH traded up $0.06 during trading on Tuesday, reaching $23.38. 1,152,125 shares of the company’s stock traded hands, compared to its average volume of 1,372,552. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.57. Evolent Health, Inc. has a fifty-two week low of $17.98 and a fifty-two week high of $35.00. The company has a 50-day simple moving average of $21.40 and a 200-day simple moving average of $27.20. The firm has a market cap of $2.72 billion, a PE ratio of -19.10 and a beta of 1.54.

Evolent Health (NYSE:EVH) last issued its quarterly earnings results on Thursday, May 9th. The technology company reported $0.16 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.12 by $0.04. Evolent Health had a positive return on equity of 6.90% and a negative net margin of 5.07%. The company had revenue of $639.65 million for the quarter, compared to the consensus estimate of $601.60 million. As a group, analysts predict that Evolent Health, Inc. will post 0.9 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on EVH shares. JMP Securities lowered their price objective on shares of Evolent Health from $38.00 to $34.00 and set a “market outperform” rating for the company in a research note on Friday, May 10th. Canaccord Genuity Group dropped their price target on Evolent Health from $44.00 to $41.00 and set a “buy” rating on the stock in a research note on Friday, May 10th. Stephens reaffirmed an “overweight” rating and set a $42.00 target price on shares of Evolent Health in a report on Tuesday. Finally, Citigroup started coverage on shares of Evolent Health in a report on Monday, April 22nd. They issued a “buy” rating and a $40.00 price target on the stock. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $42.00.

Evolent Health Profile

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.